OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Autoimmunity is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	384
GILZ regulates type I interferon release and sequesters STAT1	226
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	187
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination	131
Advances in SLE classification criteria	129
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	119
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	107
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	101
Editorial Board	98
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	95
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	89
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	88
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	81
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	80
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	76
Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk	75
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p	74
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	72
Lupus nephritis: new progress in diagnosis and treatment	71
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice	69
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia	69
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	65
Glycobiology of psoriasis: A review	63
Editorial Board	61
Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	60

Editorial Board	59
Editorial Board	57
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	54
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	53
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	52
Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus	51
Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis	49
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data	49
LAT1 enables T cell activation under inflammatory conditions	48
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort	48
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection	47
Antigenic mimicry – The key to autoimmunity in immune privileged organs	46
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus	42
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	42
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	42
The complement system and human autoimmune diseases	40